Synergy Rx GLP-1 Review (2026): Pricing, Coverage, and Tradeoffs

Item: Synergy Rx
Author: RangeYourself

Synergy Rx review, semaglutide compounded, injectable 'starting at $199/mo', oral 'starting at $299/mo' (advertised starting price, verified 2026-07-14; '2026 promo applied' banner active)., tirzepatide compounded, injectable 'starting at $349/mo', oral 'starting at $399/mo' (advertised starting price, verified 2026-07-14).. All-50-state compounded GLP-1 shoppers comparing broad menus with named pharmacies. Independent 2026 review from RangeYourself.

By RangeYourselfLast verified 2026-07-14

Quick take

Synergy Rx is compounded semaglutide and tirzepatide, injectable and oral; once-weekly at-home injection, priced as cash-pay subscription; advertised 'starting at' entry pricing with a live '2026 promo applied' banner and a $100 welcome credit. Best for: All-50-state compounded GLP-1 shoppers comparing broad menus with named pharmacies. Watch out for: The $199 semaglutide figure is an advertised 'starting at' entry price shown with a live '2026 Promo Applied' banner and a $100 welcome credit, confirm the exact ongoing rate and whether the promo is active at enrollment. Injectable tirzepatide starts at $349; oral formats cost more.

Pricing summary

Price verified: 2026-07-14 (checked against the provider’s public pricing surface)
All-in monthly cost: $199/month (medication included), advertised starting price
Semaglutide: Compounded, injectable 'starting at $199/mo', oral 'starting at $299/mo' (advertised starting price, verified 2026-07-14; '2026 Promo Applied' banner active).
Tirzepatide: Compounded, injectable 'starting at $349/mo', oral 'starting at $399/mo' (advertised starting price, verified 2026-07-14).
Compounded vs brand-name: Compounded only
Insurance accepted: No insurance-billing path published (cash-pay); confirm at signup
Consult type: Async questionnaire, per the provider’s published flow
Dose-escalation pricing: 'Starting at' entry pricing, injectable semaglutide $199, oral semaglutide $299, injectable tirzepatide $349, oral tirzepatide $399; higher doses/formats cost more. A '2026 Promo Applied' banner is active, the daily price audit watches it for reversion.
Refund policy: Cash-pay subscription; cancellation and refund terms per Synergy Rx’s policy, confirm at enrollment.
States served: All 50 US states + Washington, D.C.

Check Synergy Rx pricing →

Choose Synergy Rx if

You want compounded semaglutide or tirzepatide (injectable or oral) on a cash-pay plan in all 50 states
You value named dispensing pharmacies (Belmar, Strive, Epiq Scripts, Casa Pharma Rx)
You value an upfront compounding disclosure in the FAQ
You’re comfortable confirming the exact ongoing rate (the $199 is an advertised 'starting at' with a promo banner)

Skip Synergy Rx if

You want a stated 503A/503B pharmacy status, a locked-in non-promo price, or insurance billing.

Contraindications and clinical notes

Standard GLP-1 contraindications per GLP-1 prescribing information (personal/family history of MTC or MEN 2).. Talk to a clinician about personal or family history of medullary thyroid carcinoma, MEN 2, pancreatitis, or other conditions before starting any GLP-1 medication.

Verified programs that cost less than Synergy Rx

Synergy Rx’s own verified figure is $199/mo (advertised starting price). Every program below carries a lower all-in monthly price that we verified on the provider’s own pricing page, ranked lowest first as of September 14, 2026.

1.Embody
$69/mo (limited-time promo), verified September 5, 2026
See pricing →
2.Strut Health
$99/mo (sublingual/oral starting price), verified August 21, 2026
See pricing →
3.Trimi
$99/mo (annual-plan rate), verified August 21, 2026
See pricing →
4.HealthRX
$99/mo (12-month plan rate), verified August 21, 2026
See pricing →
5.bmiMD
$119/mo (12-month plan rate), verified September 3, 2026
See pricing →

Prices are each provider’s own published all-in monthly figure at the plan term shown, verified on the date listed. RangeYourself may earn a commission from some programs; that can only break an exact tie between verified equals and never changes the price order.

How Synergy Rx compares

Frequently asked questions

How much does Synergy Rx cost per month?

Synergy Rx's lowest verified rate is $199/month with compounded medication included. Semaglutide: Compounded, injectable 'starting at $199/mo', oral 'starting at $299/mo' (advertised starting price, verified 2026-07-14; '2026 Promo Applied' banner active).; tirzepatide: Compounded, injectable 'starting at $349/mo', oral 'starting at $399/mo' (advertised starting price, verified 2026-07-14).. 'Starting at' entry pricing, injectable semaglutide $199, oral semaglutide $299, injectable tirzepatide $349, oral tirzepatide $399; higher doses/formats cost more. A '2026 Promo Applied' banner is active, the daily price audit watches it for reversion.

Does Synergy Rx accept insurance?

Synergy Rx publishes cash-pay prices and we found no insurance-billing path on its own site. Where a provider's own FAQ leaves the door open, the answer sits inside its intake flow, which we do not enter, so confirm at signup rather than treating this as settled. If you want insurance-billed brand-name GLP-1, see our list of GLP-1 programs that accept insurance.

What states does Synergy Rx serve?

Synergy Rx ships medication to all 50 US states plus Washington, D.C.

Is Synergy Rx compounded or brand-name?

Synergy Rx prescribes compounded semaglutide and tirzepatide via state-licensed 503A pharmacies or 503B outsourcing facilities. Compounded medication is not individually FDA-approved. The shortage-era compounding pathway ended after the FDA declared the semaglutide shortage resolved on February 21, 2025 and the tirzepatide shortage resolved in December 2024, so compounding now proceeds under the ordinary rules for individual patients.

What's the catch with Synergy Rx?

The $199 semaglutide figure is an advertised 'starting at' entry price shown with a live '2026 Promo Applied' banner and a $100 welcome credit, confirm the exact ongoing rate and whether the promo is active at enrollment. Injectable tirzepatide starts at $349; oral formats cost more. Avoid if: you want a stated 503a/503b pharmacy status, a locked-in non-promo price, or insurance billing.

Related guides

Synergy Rx availability by state

GLP-1 programs in California , where Synergy Rx ships and how it stacks up locally.
GLP-1 programs in Texas , where Synergy Rx ships and how it stacks up locally.
GLP-1 programs in Florida , where Synergy Rx ships and how it stacks up locally.
GLP-1 programs in New York , where Synergy Rx ships and how it stacks up locally.
GLP-1 programs in Illinois , where Synergy Rx ships and how it stacks up locally.

About compounded GLP-1 medicationsCompounded semaglutide and tirzepatide are not FDA-approved finished products. They are prepared by state-licensed 503A pharmacies or 503B outsourcing facilities and are not individually reviewed by the FDA for safety, effectiveness, or quality. Compounders describe these preparations as using the same active ingredient as the approved medicines; the FDA has warned that some compounded products use salt forms, semaglutide sodium or semaglutide acetate, that it considers different active ingredients from the approved drug, and has issued warning letters over marketing that presents a compounded preparation as interchangeable with an approved one. The FDA declared the semaglutide shortage resolved on February 21, 2025 and the tirzepatide shortage resolved in December 2024, so the shortage-era pathway for broad compounding of these drugs has ended. Compounding now proceeds under the ordinary rules: a 503A pharmacy compounding for an individual patient on a prescription, or a 503B outsourcing facility, which compounds in bulk under CGMP and FDA registration rather than per patient. Those rules generally do not cover a product that is “essentially a copy” of an approved drug unless a prescriber documents a change that makes a significant difference for an individual patient. Talk to a clinician about contraindications including personal or family history of medullary thyroid carcinoma or MEN 2. RangeYourself does not provide medical advice, does not guarantee a prescription, and does not guarantee weight-loss results.

RangeYourself is reader-supported. We may earn a commission when you click on certain links, at no extra cost to you. Editorial recommendations are made independently. Pricing reflects publicly listed entry tiers verified on 2026-07-14 and may change.